The cost-effectiveness of targeted or universal screening for vasa praevia at 18-20 weeks of gestation in Ontario

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 9, 2010, Pages 1108-1118

  Cipriano, L E ^a   Barth Jr , Wh ^b,c   Zaric, G S ^d  

^a Stanford University   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

cost effectiveness analysis; prenatal diagnosis; screening; ultrasonography; ultrasound; Vasa praevia

Indexed keywords

ARTICLE; CANADA; COHORT ANALYSIS; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; FERTILIZATION IN VITRO; GESTATIONAL AGE; HEALTH INSURANCE; HEALTH SCIENCE; HUMAN; LIFE EXPECTANCY; LIFESPAN; PRENATAL SCREENING; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; SENSITIVITY ANALYSIS; TRANSVAGINAL ECHOGRAPHY; TWIN PREGNANCY; UMBILICAL CORD COMPLICATION; VASA PREVIA; ADULT; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECHOGRAPHY; ECONOMICS; EVALUATION STUDY; FETUS ECHOGRAPHY; MULTICENTER STUDY; MULTIPLE PREGNANCY; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; PROCEDURES; SECOND TRIMESTER PREGNANCY; TWINS;

ADULT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFANT, NEWBORN; LIFE EXPECTANCY; ONTARIO; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREGNANCY, MULTIPLE; QUALITY-ADJUSTED LIFE YEARS; TWINS; ULTRASONOGRAPHY, PRENATAL; VASA PREVIA;

EID: 77954420440     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02621.x     Document Type: Article

References (34)

1. Benirschke K, Kaufmann P. Pathology of the Human Placenta, 4th edn.
2. Fung TY, Lau TK. Poor perinatal outcome associated with vasa previa: is it preventable? A report of three cases and review of the literature. Ultrasound Obstet Gynecol 1998 12 : 430 433.
3. Oyelese Y, Catanzarite V, Prefumo F, Lashley S, Schachter M, Tovbin Y, et al. Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol 2004 103 : 937 942. (Pubitemid 40458995)
4. Schachter M, Tovbin Y, Arieli S, Friedler S, Ron-El R, Sherman D. In vitro fertilization is a risk factor for vasa previa. Fertil Steril 2002 78 : 642 643.
5. Baulies S, Maiz N, Munoz A, Torrents M, Echevarria M, Serra B. Prenatal ultrasound diagnosis of vasa praevia and analysis of risk factors. Prenat Diagn 2007 27 : 595 599.
6. Lee W, Lee VL, Kirk JS, Sloan CT, Smith RS, Comstock CH. Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome. Obstet Gynecol 2000 95 : 572 576.
7. Pretorius DH, Chau C, Poeltler DM, Mendoza A, Catanzarite VA, Hollenbach KA. Placental cord insertion visualization with prenatal ultrasonography. J Ultrasound Med 1996 15 : 585 593.
8. Catanzarite V, Maida C, Thomas W, Mendoza A, Stanco L, Piacquadio KM. Prenatal sonographic diagnosis of vasa previa: ultrasound findings and obstetric outcome in ten cases. Ultrasound Obstet Gynecol 2001 18 : 109 115.
9. Al-Khaduri M, Kadoch IJ, Couturier B, Dube J, Lapensee L, Bissonnette F. Vasa praevia after IVF: should there be guidelines? Report of two cases and literature review. Reprod Biomed online 2007 14 : 372 374.
10. Oyelese KO, Schwarzler P, Coates S, Sanusi FA, Hamid R, Campbell S. A strategy for reducing the mortality rate from vasa previa using transvaginal sonography with color Doppler. Ultrasound Obstet Gynecol 1998 12 : 434 438.
11. Gandhi M, Cleary-Goldman J, Ferrara L, Ciorica D, Saltzman D, Rebarber A. The association between vasa previa, multiple gestations, and assisted reproductive technology. Am J Perinatol 2008 25 : 587 589.
12. Sinha P, Kaushik S, Kuruba N, Beweley S. Vasa praevia: a missed diagnosis. J Obstet Gynecol 2008 28 : 600 603.
13. CBC news. Couple urges routine screening for pregnancy condition. 2007 http://www.cbc.ca/health/story/2007/03/22/vasa-previa-070322.html ]. Accessed 22 March 2007.
14. The Society of Obstetricians and Gynaecologists of Canada (SOGC). Committee Opinion No. 103: content of a complete obstetrical ultrasound report.
15. The Society of Obstetricians and Gynaecologists of Canada (SOGC). Clinical Practice Guideline No. 187: Prenatal Screening for Fetal Aneuploidy.
16. Gagnon R, Morin L, Bly S, Butt K, Cargill YM, Denis N, et al. Guidelines for the management of vasa previa. J Obstet Gynaecol Can 2009 31 : 748 760.
17. Statistics Canada. Table 102-4515 - Live births and fetal deaths (stillbirths), by type (single or multiple), Canada, provinces and territories, annual (number).
18. Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies: Canada, 3rd edn.
19. Statistics Canada. Table 326-0021 - Consumer Price Index (CPI), 2005 Basket Content, Annual.
20. Ministry of Health and Long Term Care. Schedule of Benefits: Physician Services under the Health Insurance Act.
21. London Health Sciences Centre. Case Costing (Internal Document).
22. Manuel DG, Schultz SE. Using linked data to calculate summary measures of population health: health-adjusted life expectancy of people with diabetes mellitus. Popul Health Metr 2004 2 : 4.
23. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992 146 : 473 481.
24. Ioannou C, Wayne C. Diagnosis and management of vasa previa: a questionnaire survey. Ultrasound Obstet Gynecol 2009 33 : 552 559.
25. Sepulveda W, Rojas I, Robert JA, Schnapp C, Alcalde JL. Prenatal detection of velamentous insertion of the umbilical cord: a prospective color Doppler ultrasound study. Ultrasound Obstet Gynecol 2003 21 : 564 569.
26. Sepulveda W. Velamentous insertion of the umbilical cord: a first-trimester sonographic screening study. J Ultrasound Med 2006 25 : 963 968 quiz 70.
27. Vago T, Caspi E. Antepartum bleeding due to injury of velamentous placental vessels. Obstet Gynecol 1962 20 : 671 674.
28. Baschat AA, Gembruch U. Ante- and intrapartum diagnosis of vasa praevia in singleton pregnancies by colour coded Doppler sonography. Eur J Obstet Gynecol Reprod Biol 1998 79 : 19 25.
29. Gunby J, Daya S. Assisted reproductive technologies (ART) in Canada: 2003 results from the Canadian ART Register. Fertil Steril 2007 88 : 550 559.
30. Becker RH, Vonk R, Mende BC, Ragosch V, Entezami M. The relevance of placental location at 20-23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases. Ultrasound Obstet Gynecol 2001 17 : 496 501.
31. Naeye RL. Disorders of the Placenta, Fetus, and Neonate: Diagnosis and Clinical Significance.
32. Nomiyama M, Toyota Y, Kawano H. Antenatal diagnosis of velamentous umbilical cord insertion and vasa previa with color Doppler imaging. Ultrasound Obstet Gynecol 1998 12 : 426 429.
33. Vintzileos AM, Beazoglou T. Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics. Am J Obstet Gynecol 2004 191 : 1070 1076.
34. Eddama O, Petrou S, Schroeder L, Bollapragada SS, MacKenzie F, Norrie J, et al. The cost-effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG 2009 116 : 1196 1203.